Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Mylan NV (NASDAQ:MYL)

During the Trading Day
41.83 +0.405 / +0.98%
As of 4:00pm ET
Day’s Change
During After-Hours   Switch to standard view »
41.60 -0.225 / -0.54%
 
Volume: 981.7K

Today’s Trading

Previous close41.42
Today’s open41.34
Day’s range40.05 - 42.00
Volume15,531,140
Average volume (3 months)7,751,055
Market cap$20.4B
Dividend yield--
Data as of 4:00pm ET, 02/12/2016

Growth & Valuation

Earnings growth (last year)+48.10%
Earnings growth (this year)+21.64%
Earnings growth (next 5 years)+10.31%
Revenue growth (last year)+11.45%
P/E ratio18.0
Price/Sales2.89
Price/Book4.77

Competitors

 Today’s
change
Today’s
% change
PRGOPerrigo Company PLC+3.53+2.61%
ZTSZoetis Inc+1.07+2.72%
VRTXVertex Pharmaceutica...+3.52+4.42%
VRXValeant Pharmaceutic...+4.95+5.93%
Data as of 4:02pm ET, 02/12/2016

Financials

Next reporting dateApril 28, 2016
EPS forecast (this quarter)$1.03
Annual revenue (last year)$7.8B
Annual profit (last year)$929.4M
Net profit margin11.97%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
Chief Executive Officer &
Executive Director
Heather M. Bresch
President &
Executive Director
Rajiv Malik
Corporate headquarters
Potters Bar, Hertfordshire

Forecasts

Partner Offers